Global Live Attenuated Measles Vaccine Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Live Attenuated Measles Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Live Attenuated Measles Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Live Attenuated Measles Vaccine market in any manner.
Global Live Attenuated Measles Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GSK
Sanofi-Pasteur
Merck
Pfizer
Serum Institute of India
Novartis
Emergent Biosolutions
Bavarian Nordic
Medimmune
Johnson & Johnson
CSL Limited
Changchun Qijian Biological Products Co., Ltd
Beijing Institute of Biological Products Co., Ltd
Wuhan Institute of Biological Products Co., Ltd
Shanghai Institute of Biological Products Co., Ltd
Lanzhou Institute of Biological Products Co., Ltd
Market Segmentation (by Type)
Liquid
Powder
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Live Attenuated Measles Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Live Attenuated Measles Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Live Attenuated Measles Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Live Attenuated Measles Vaccine market in any manner.
Global Live Attenuated Measles Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GSK
Sanofi-Pasteur
Merck
Pfizer
Serum Institute of India
Novartis
Emergent Biosolutions
Bavarian Nordic
Medimmune
Johnson & Johnson
CSL Limited
Changchun Qijian Biological Products Co., Ltd
Beijing Institute of Biological Products Co., Ltd
Wuhan Institute of Biological Products Co., Ltd
Shanghai Institute of Biological Products Co., Ltd
Lanzhou Institute of Biological Products Co., Ltd
Market Segmentation (by Type)
Liquid
Powder
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Live Attenuated Measles Vaccine Market
- Overview of the regional outlook of the Live Attenuated Measles Vaccine Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Live Attenuated Measles Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Live Attenuated Measles Vaccine
1.2 Key Market Segments
1.2.1 Live Attenuated Measles Vaccine Segment by Type
1.2.2 Live Attenuated Measles Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LIVE ATTENUATED MEASLES VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Live Attenuated Measles Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Live Attenuated Measles Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LIVE ATTENUATED MEASLES VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Live Attenuated Measles Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Live Attenuated Measles Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Live Attenuated Measles Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Live Attenuated Measles Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Live Attenuated Measles Vaccine Sales Sites, Area Served, Product Type
3.6 Live Attenuated Measles Vaccine Market Competitive Situation and Trends
3.6.1 Live Attenuated Measles Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Live Attenuated Measles Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LIVE ATTENUATED MEASLES VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Live Attenuated Measles Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LIVE ATTENUATED MEASLES VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 LIVE ATTENUATED MEASLES VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Live Attenuated Measles Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Live Attenuated Measles Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Live Attenuated Measles Vaccine Price by Type (2019-2024)
7 LIVE ATTENUATED MEASLES VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Live Attenuated Measles Vaccine Market Sales by Application (2019-2024)
7.3 Global Live Attenuated Measles Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Live Attenuated Measles Vaccine Sales Growth Rate by Application (2019-2024)
8 LIVE ATTENUATED MEASLES VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Live Attenuated Measles Vaccine Sales by Region
8.1.1 Global Live Attenuated Measles Vaccine Sales by Region
8.1.2 Global Live Attenuated Measles Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Live Attenuated Measles Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Live Attenuated Measles Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Live Attenuated Measles Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Live Attenuated Measles Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Live Attenuated Measles Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GSK
9.1.1 GSK Live Attenuated Measles Vaccine Basic Information
9.1.2 GSK Live Attenuated Measles Vaccine Product Overview
9.1.3 GSK Live Attenuated Measles Vaccine Product Market Performance
9.1.4 GSK Business Overview
9.1.5 GSK Live Attenuated Measles Vaccine SWOT Analysis
9.1.6 GSK Recent Developments
9.2 Sanofi-Pasteur
9.2.1 Sanofi-Pasteur Live Attenuated Measles Vaccine Basic Information
9.2.2 Sanofi-Pasteur Live Attenuated Measles Vaccine Product Overview
9.2.3 Sanofi-Pasteur Live Attenuated Measles Vaccine Product Market Performance
9.2.4 Sanofi-Pasteur Business Overview
9.2.5 Sanofi-Pasteur Live Attenuated Measles Vaccine SWOT Analysis
9.2.6 Sanofi-Pasteur Recent Developments
9.3 Merck
9.3.1 Merck Live Attenuated Measles Vaccine Basic Information
9.3.2 Merck Live Attenuated Measles Vaccine Product Overview
9.3.3 Merck Live Attenuated Measles Vaccine Product Market Performance
9.3.4 Merck Live Attenuated Measles Vaccine SWOT Analysis
9.3.5 Merck Business Overview
9.3.6 Merck Recent Developments
9.4 Pfizer
9.4.1 Pfizer Live Attenuated Measles Vaccine Basic Information
9.4.2 Pfizer Live Attenuated Measles Vaccine Product Overview
9.4.3 Pfizer Live Attenuated Measles Vaccine Product Market Performance
9.4.4 Pfizer Business Overview
9.4.5 Pfizer Recent Developments
9.5 Serum Institute of India
9.5.1 Serum Institute of India Live Attenuated Measles Vaccine Basic Information
9.5.2 Serum Institute of India Live Attenuated Measles Vaccine Product Overview
9.5.3 Serum Institute of India Live Attenuated Measles Vaccine Product Market Performance
9.5.4 Serum Institute of India Business Overview
9.5.5 Serum Institute of India Recent Developments
9.6 Novartis
9.6.1 Novartis Live Attenuated Measles Vaccine Basic Information
9.6.2 Novartis Live Attenuated Measles Vaccine Product Overview
9.6.3 Novartis Live Attenuated Measles Vaccine Product Market Performance
9.6.4 Novartis Business Overview
9.6.5 Novartis Recent Developments
9.7 Emergent Biosolutions
9.7.1 Emergent Biosolutions Live Attenuated Measles Vaccine Basic Information
9.7.2 Emergent Biosolutions Live Attenuated Measles Vaccine Product Overview
9.7.3 Emergent Biosolutions Live Attenuated Measles Vaccine Product Market Performance
9.7.4 Emergent Biosolutions Business Overview
9.7.5 Emergent Biosolutions Recent Developments
9.8 Bavarian Nordic
9.8.1 Bavarian Nordic Live Attenuated Measles Vaccine Basic Information
9.8.2 Bavarian Nordic Live Attenuated Measles Vaccine Product Overview
9.8.3 Bavarian Nordic Live Attenuated Measles Vaccine Product Market Performance
9.8.4 Bavarian Nordic Business Overview
9.8.5 Bavarian Nordic Recent Developments
9.9 Medimmune
9.9.1 Medimmune Live Attenuated Measles Vaccine Basic Information
9.9.2 Medimmune Live Attenuated Measles Vaccine Product Overview
9.9.3 Medimmune Live Attenuated Measles Vaccine Product Market Performance
9.9.4 Medimmune Business Overview
9.9.5 Medimmune Recent Developments
9.10 Johnson and Johnson
9.10.1 Johnson and Johnson Live Attenuated Measles Vaccine Basic Information
9.10.2 Johnson and Johnson Live Attenuated Measles Vaccine Product Overview
9.10.3 Johnson and Johnson Live Attenuated Measles Vaccine Product Market Performance
9.10.4 Johnson and Johnson Business Overview
9.10.5 Johnson and Johnson Recent Developments
9.11 CSL Limited
9.11.1 CSL Limited Live Attenuated Measles Vaccine Basic Information
9.11.2 CSL Limited Live Attenuated Measles Vaccine Product Overview
9.11.3 CSL Limited Live Attenuated Measles Vaccine Product Market Performance
9.11.4 CSL Limited Business Overview
9.11.5 CSL Limited Recent Developments
9.12 Changchun Qijian Biological Products Co., Ltd
9.12.1 Changchun Qijian Biological Products Co., Ltd Live Attenuated Measles Vaccine Basic Information
9.12.2 Changchun Qijian Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Overview
9.12.3 Changchun Qijian Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Market Performance
9.12.4 Changchun Qijian Biological Products Co., Ltd Business Overview
9.12.5 Changchun Qijian Biological Products Co., Ltd Recent Developments
9.13 Beijing Institute of Biological Products Co., Ltd
9.13.1 Beijing Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Basic Information
9.13.2 Beijing Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Overview
9.13.3 Beijing Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Market Performance
9.13.4 Beijing Institute of Biological Products Co., Ltd Business Overview
9.13.5 Beijing Institute of Biological Products Co., Ltd Recent Developments
9.14 Wuhan Institute of Biological Products Co., Ltd
9.14.1 Wuhan Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Basic Information
9.14.2 Wuhan Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Overview
9.14.3 Wuhan Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Market Performance
9.14.4 Wuhan Institute of Biological Products Co., Ltd Business Overview
9.14.5 Wuhan Institute of Biological Products Co., Ltd Recent Developments
9.15 Shanghai Institute of Biological Products Co., Ltd
9.15.1 Shanghai Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Basic Information
9.15.2 Shanghai Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Overview
9.15.3 Shanghai Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Market Performance
9.15.4 Shanghai Institute of Biological Products Co., Ltd Business Overview
9.15.5 Shanghai Institute of Biological Products Co., Ltd Recent Developments
9.16 Lanzhou Institute of Biological Products Co., Ltd
9.16.1 Lanzhou Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Basic Information
9.16.2 Lanzhou Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Overview
9.16.3 Lanzhou Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Market Performance
9.16.4 Lanzhou Institute of Biological Products Co., Ltd Business Overview
9.16.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments
10 LIVE ATTENUATED MEASLES VACCINE MARKET FORECAST BY REGION
10.1 Global Live Attenuated Measles Vaccine Market Size Forecast
10.2 Global Live Attenuated Measles Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Live Attenuated Measles Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Live Attenuated Measles Vaccine Market Size Forecast by Region
10.2.4 South America Live Attenuated Measles Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Live Attenuated Measles Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Live Attenuated Measles Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Live Attenuated Measles Vaccine by Type (2025-2030)
11.1.2 Global Live Attenuated Measles Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Live Attenuated Measles Vaccine by Type (2025-2030)
11.2 Global Live Attenuated Measles Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Live Attenuated Measles Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Live Attenuated Measles Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Live Attenuated Measles Vaccine
1.2 Key Market Segments
1.2.1 Live Attenuated Measles Vaccine Segment by Type
1.2.2 Live Attenuated Measles Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LIVE ATTENUATED MEASLES VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Live Attenuated Measles Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Live Attenuated Measles Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LIVE ATTENUATED MEASLES VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Live Attenuated Measles Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Live Attenuated Measles Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Live Attenuated Measles Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Live Attenuated Measles Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Live Attenuated Measles Vaccine Sales Sites, Area Served, Product Type
3.6 Live Attenuated Measles Vaccine Market Competitive Situation and Trends
3.6.1 Live Attenuated Measles Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Live Attenuated Measles Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LIVE ATTENUATED MEASLES VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Live Attenuated Measles Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LIVE ATTENUATED MEASLES VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 LIVE ATTENUATED MEASLES VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Live Attenuated Measles Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Live Attenuated Measles Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Live Attenuated Measles Vaccine Price by Type (2019-2024)
7 LIVE ATTENUATED MEASLES VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Live Attenuated Measles Vaccine Market Sales by Application (2019-2024)
7.3 Global Live Attenuated Measles Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Live Attenuated Measles Vaccine Sales Growth Rate by Application (2019-2024)
8 LIVE ATTENUATED MEASLES VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Live Attenuated Measles Vaccine Sales by Region
8.1.1 Global Live Attenuated Measles Vaccine Sales by Region
8.1.2 Global Live Attenuated Measles Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Live Attenuated Measles Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Live Attenuated Measles Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Live Attenuated Measles Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Live Attenuated Measles Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Live Attenuated Measles Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GSK
9.1.1 GSK Live Attenuated Measles Vaccine Basic Information
9.1.2 GSK Live Attenuated Measles Vaccine Product Overview
9.1.3 GSK Live Attenuated Measles Vaccine Product Market Performance
9.1.4 GSK Business Overview
9.1.5 GSK Live Attenuated Measles Vaccine SWOT Analysis
9.1.6 GSK Recent Developments
9.2 Sanofi-Pasteur
9.2.1 Sanofi-Pasteur Live Attenuated Measles Vaccine Basic Information
9.2.2 Sanofi-Pasteur Live Attenuated Measles Vaccine Product Overview
9.2.3 Sanofi-Pasteur Live Attenuated Measles Vaccine Product Market Performance
9.2.4 Sanofi-Pasteur Business Overview
9.2.5 Sanofi-Pasteur Live Attenuated Measles Vaccine SWOT Analysis
9.2.6 Sanofi-Pasteur Recent Developments
9.3 Merck
9.3.1 Merck Live Attenuated Measles Vaccine Basic Information
9.3.2 Merck Live Attenuated Measles Vaccine Product Overview
9.3.3 Merck Live Attenuated Measles Vaccine Product Market Performance
9.3.4 Merck Live Attenuated Measles Vaccine SWOT Analysis
9.3.5 Merck Business Overview
9.3.6 Merck Recent Developments
9.4 Pfizer
9.4.1 Pfizer Live Attenuated Measles Vaccine Basic Information
9.4.2 Pfizer Live Attenuated Measles Vaccine Product Overview
9.4.3 Pfizer Live Attenuated Measles Vaccine Product Market Performance
9.4.4 Pfizer Business Overview
9.4.5 Pfizer Recent Developments
9.5 Serum Institute of India
9.5.1 Serum Institute of India Live Attenuated Measles Vaccine Basic Information
9.5.2 Serum Institute of India Live Attenuated Measles Vaccine Product Overview
9.5.3 Serum Institute of India Live Attenuated Measles Vaccine Product Market Performance
9.5.4 Serum Institute of India Business Overview
9.5.5 Serum Institute of India Recent Developments
9.6 Novartis
9.6.1 Novartis Live Attenuated Measles Vaccine Basic Information
9.6.2 Novartis Live Attenuated Measles Vaccine Product Overview
9.6.3 Novartis Live Attenuated Measles Vaccine Product Market Performance
9.6.4 Novartis Business Overview
9.6.5 Novartis Recent Developments
9.7 Emergent Biosolutions
9.7.1 Emergent Biosolutions Live Attenuated Measles Vaccine Basic Information
9.7.2 Emergent Biosolutions Live Attenuated Measles Vaccine Product Overview
9.7.3 Emergent Biosolutions Live Attenuated Measles Vaccine Product Market Performance
9.7.4 Emergent Biosolutions Business Overview
9.7.5 Emergent Biosolutions Recent Developments
9.8 Bavarian Nordic
9.8.1 Bavarian Nordic Live Attenuated Measles Vaccine Basic Information
9.8.2 Bavarian Nordic Live Attenuated Measles Vaccine Product Overview
9.8.3 Bavarian Nordic Live Attenuated Measles Vaccine Product Market Performance
9.8.4 Bavarian Nordic Business Overview
9.8.5 Bavarian Nordic Recent Developments
9.9 Medimmune
9.9.1 Medimmune Live Attenuated Measles Vaccine Basic Information
9.9.2 Medimmune Live Attenuated Measles Vaccine Product Overview
9.9.3 Medimmune Live Attenuated Measles Vaccine Product Market Performance
9.9.4 Medimmune Business Overview
9.9.5 Medimmune Recent Developments
9.10 Johnson and Johnson
9.10.1 Johnson and Johnson Live Attenuated Measles Vaccine Basic Information
9.10.2 Johnson and Johnson Live Attenuated Measles Vaccine Product Overview
9.10.3 Johnson and Johnson Live Attenuated Measles Vaccine Product Market Performance
9.10.4 Johnson and Johnson Business Overview
9.10.5 Johnson and Johnson Recent Developments
9.11 CSL Limited
9.11.1 CSL Limited Live Attenuated Measles Vaccine Basic Information
9.11.2 CSL Limited Live Attenuated Measles Vaccine Product Overview
9.11.3 CSL Limited Live Attenuated Measles Vaccine Product Market Performance
9.11.4 CSL Limited Business Overview
9.11.5 CSL Limited Recent Developments
9.12 Changchun Qijian Biological Products Co., Ltd
9.12.1 Changchun Qijian Biological Products Co., Ltd Live Attenuated Measles Vaccine Basic Information
9.12.2 Changchun Qijian Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Overview
9.12.3 Changchun Qijian Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Market Performance
9.12.4 Changchun Qijian Biological Products Co., Ltd Business Overview
9.12.5 Changchun Qijian Biological Products Co., Ltd Recent Developments
9.13 Beijing Institute of Biological Products Co., Ltd
9.13.1 Beijing Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Basic Information
9.13.2 Beijing Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Overview
9.13.3 Beijing Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Market Performance
9.13.4 Beijing Institute of Biological Products Co., Ltd Business Overview
9.13.5 Beijing Institute of Biological Products Co., Ltd Recent Developments
9.14 Wuhan Institute of Biological Products Co., Ltd
9.14.1 Wuhan Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Basic Information
9.14.2 Wuhan Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Overview
9.14.3 Wuhan Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Market Performance
9.14.4 Wuhan Institute of Biological Products Co., Ltd Business Overview
9.14.5 Wuhan Institute of Biological Products Co., Ltd Recent Developments
9.15 Shanghai Institute of Biological Products Co., Ltd
9.15.1 Shanghai Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Basic Information
9.15.2 Shanghai Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Overview
9.15.3 Shanghai Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Market Performance
9.15.4 Shanghai Institute of Biological Products Co., Ltd Business Overview
9.15.5 Shanghai Institute of Biological Products Co., Ltd Recent Developments
9.16 Lanzhou Institute of Biological Products Co., Ltd
9.16.1 Lanzhou Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Basic Information
9.16.2 Lanzhou Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Overview
9.16.3 Lanzhou Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Market Performance
9.16.4 Lanzhou Institute of Biological Products Co., Ltd Business Overview
9.16.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments
10 LIVE ATTENUATED MEASLES VACCINE MARKET FORECAST BY REGION
10.1 Global Live Attenuated Measles Vaccine Market Size Forecast
10.2 Global Live Attenuated Measles Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Live Attenuated Measles Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Live Attenuated Measles Vaccine Market Size Forecast by Region
10.2.4 South America Live Attenuated Measles Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Live Attenuated Measles Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Live Attenuated Measles Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Live Attenuated Measles Vaccine by Type (2025-2030)
11.1.2 Global Live Attenuated Measles Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Live Attenuated Measles Vaccine by Type (2025-2030)
11.2 Global Live Attenuated Measles Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Live Attenuated Measles Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Live Attenuated Measles Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Live Attenuated Measles Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Live Attenuated Measles Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Live Attenuated Measles Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Live Attenuated Measles Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Live Attenuated Measles Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Attenuated Measles Vaccine as of 2022)
Table 10. Global Market Live Attenuated Measles Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Live Attenuated Measles Vaccine Sales Sites and Area Served
Table 12. Manufacturers Live Attenuated Measles Vaccine Product Type
Table 13. Global Live Attenuated Measles Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Live Attenuated Measles Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Live Attenuated Measles Vaccine Market Challenges
Table 22. Global Live Attenuated Measles Vaccine Sales by Type (Kilotons)
Table 23. Global Live Attenuated Measles Vaccine Market Size by Type (M USD)
Table 24. Global Live Attenuated Measles Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Live Attenuated Measles Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Live Attenuated Measles Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Live Attenuated Measles Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Live Attenuated Measles Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Live Attenuated Measles Vaccine Sales (Kilotons) by Application
Table 30. Global Live Attenuated Measles Vaccine Market Size by Application
Table 31. Global Live Attenuated Measles Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Live Attenuated Measles Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Live Attenuated Measles Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Live Attenuated Measles Vaccine Market Share by Application (2019-2024)
Table 35. Global Live Attenuated Measles Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Live Attenuated Measles Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Live Attenuated Measles Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Live Attenuated Measles Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Live Attenuated Measles Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Live Attenuated Measles Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Live Attenuated Measles Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Live Attenuated Measles Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. GSK Live Attenuated Measles Vaccine Basic Information
Table 44. GSK Live Attenuated Measles Vaccine Product Overview
Table 45. GSK Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. GSK Business Overview
Table 47. GSK Live Attenuated Measles Vaccine SWOT Analysis
Table 48. GSK Recent Developments
Table 49. Sanofi-Pasteur Live Attenuated Measles Vaccine Basic Information
Table 50. Sanofi-Pasteur Live Attenuated Measles Vaccine Product Overview
Table 51. Sanofi-Pasteur Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Sanofi-Pasteur Business Overview
Table 53. Sanofi-Pasteur Live Attenuated Measles Vaccine SWOT Analysis
Table 54. Sanofi-Pasteur Recent Developments
Table 55. Merck Live Attenuated Measles Vaccine Basic Information
Table 56. Merck Live Attenuated Measles Vaccine Product Overview
Table 57. Merck Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Merck Live Attenuated Measles Vaccine SWOT Analysis
Table 59. Merck Business Overview
Table 60. Merck Recent Developments
Table 61. Pfizer Live Attenuated Measles Vaccine Basic Information
Table 62. Pfizer Live Attenuated Measles Vaccine Product Overview
Table 63. Pfizer Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Pfizer Business Overview
Table 65. Pfizer Recent Developments
Table 66. Serum Institute of India Live Attenuated Measles Vaccine Basic Information
Table 67. Serum Institute of India Live Attenuated Measles Vaccine Product Overview
Table 68. Serum Institute of India Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Serum Institute of India Business Overview
Table 70. Serum Institute of India Recent Developments
Table 71. Novartis Live Attenuated Measles Vaccine Basic Information
Table 72. Novartis Live Attenuated Measles Vaccine Product Overview
Table 73. Novartis Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Novartis Business Overview
Table 75. Novartis Recent Developments
Table 76. Emergent Biosolutions Live Attenuated Measles Vaccine Basic Information
Table 77. Emergent Biosolutions Live Attenuated Measles Vaccine Product Overview
Table 78. Emergent Biosolutions Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Emergent Biosolutions Business Overview
Table 80. Emergent Biosolutions Recent Developments
Table 81. Bavarian Nordic Live Attenuated Measles Vaccine Basic Information
Table 82. Bavarian Nordic Live Attenuated Measles Vaccine Product Overview
Table 83. Bavarian Nordic Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Bavarian Nordic Business Overview
Table 85. Bavarian Nordic Recent Developments
Table 86. Medimmune Live Attenuated Measles Vaccine Basic Information
Table 87. Medimmune Live Attenuated Measles Vaccine Product Overview
Table 88. Medimmune Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Medimmune Business Overview
Table 90. Medimmune Recent Developments
Table 91. Johnson and Johnson Live Attenuated Measles Vaccine Basic Information
Table 92. Johnson and Johnson Live Attenuated Measles Vaccine Product Overview
Table 93. Johnson and Johnson Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Johnson and Johnson Business Overview
Table 95. Johnson and Johnson Recent Developments
Table 96. CSL Limited Live Attenuated Measles Vaccine Basic Information
Table 97. CSL Limited Live Attenuated Measles Vaccine Product Overview
Table 98. CSL Limited Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. CSL Limited Business Overview
Table 100. CSL Limited Recent Developments
Table 101. Changchun Qijian Biological Products Co., Ltd Live Attenuated Measles Vaccine Basic Information
Table 102. Changchun Qijian Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Overview
Table 103. Changchun Qijian Biological Products Co., Ltd Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Changchun Qijian Biological Products Co., Ltd Business Overview
Table 105. Changchun Qijian Biological Products Co., Ltd Recent Developments
Table 106. Beijing Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Basic Information
Table 107. Beijing Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Overview
Table 108. Beijing Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Beijing Institute of Biological Products Co., Ltd Business Overview
Table 110. Beijing Institute of Biological Products Co., Ltd Recent Developments
Table 111. Wuhan Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Basic Information
Table 112. Wuhan Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Overview
Table 113. Wuhan Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Wuhan Institute of Biological Products Co., Ltd Business Overview
Table 115. Wuhan Institute of Biological Products Co., Ltd Recent Developments
Table 116. Shanghai Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Basic Information
Table 117. Shanghai Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Overview
Table 118. Shanghai Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Shanghai Institute of Biological Products Co., Ltd Business Overview
Table 120. Shanghai Institute of Biological Products Co., Ltd Recent Developments
Table 121. Lanzhou Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Basic Information
Table 122. Lanzhou Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Overview
Table 123. Lanzhou Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Lanzhou Institute of Biological Products Co., Ltd Business Overview
Table 125. Lanzhou Institute of Biological Products Co., Ltd Recent Developments
Table 126. Global Live Attenuated Measles Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global Live Attenuated Measles Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Live Attenuated Measles Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America Live Attenuated Measles Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Live Attenuated Measles Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe Live Attenuated Measles Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Live Attenuated Measles Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific Live Attenuated Measles Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Live Attenuated Measles Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America Live Attenuated Measles Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Live Attenuated Measles Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Live Attenuated Measles Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Live Attenuated Measles Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global Live Attenuated Measles Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Live Attenuated Measles Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global Live Attenuated Measles Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global Live Attenuated Measles Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Live Attenuated Measles Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Live Attenuated Measles Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Live Attenuated Measles Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Live Attenuated Measles Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Live Attenuated Measles Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Attenuated Measles Vaccine as of 2022)
Table 10. Global Market Live Attenuated Measles Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Live Attenuated Measles Vaccine Sales Sites and Area Served
Table 12. Manufacturers Live Attenuated Measles Vaccine Product Type
Table 13. Global Live Attenuated Measles Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Live Attenuated Measles Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Live Attenuated Measles Vaccine Market Challenges
Table 22. Global Live Attenuated Measles Vaccine Sales by Type (Kilotons)
Table 23. Global Live Attenuated Measles Vaccine Market Size by Type (M USD)
Table 24. Global Live Attenuated Measles Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Live Attenuated Measles Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Live Attenuated Measles Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Live Attenuated Measles Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Live Attenuated Measles Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Live Attenuated Measles Vaccine Sales (Kilotons) by Application
Table 30. Global Live Attenuated Measles Vaccine Market Size by Application
Table 31. Global Live Attenuated Measles Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Live Attenuated Measles Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Live Attenuated Measles Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Live Attenuated Measles Vaccine Market Share by Application (2019-2024)
Table 35. Global Live Attenuated Measles Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Live Attenuated Measles Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Live Attenuated Measles Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Live Attenuated Measles Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Live Attenuated Measles Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Live Attenuated Measles Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Live Attenuated Measles Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Live Attenuated Measles Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. GSK Live Attenuated Measles Vaccine Basic Information
Table 44. GSK Live Attenuated Measles Vaccine Product Overview
Table 45. GSK Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. GSK Business Overview
Table 47. GSK Live Attenuated Measles Vaccine SWOT Analysis
Table 48. GSK Recent Developments
Table 49. Sanofi-Pasteur Live Attenuated Measles Vaccine Basic Information
Table 50. Sanofi-Pasteur Live Attenuated Measles Vaccine Product Overview
Table 51. Sanofi-Pasteur Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Sanofi-Pasteur Business Overview
Table 53. Sanofi-Pasteur Live Attenuated Measles Vaccine SWOT Analysis
Table 54. Sanofi-Pasteur Recent Developments
Table 55. Merck Live Attenuated Measles Vaccine Basic Information
Table 56. Merck Live Attenuated Measles Vaccine Product Overview
Table 57. Merck Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Merck Live Attenuated Measles Vaccine SWOT Analysis
Table 59. Merck Business Overview
Table 60. Merck Recent Developments
Table 61. Pfizer Live Attenuated Measles Vaccine Basic Information
Table 62. Pfizer Live Attenuated Measles Vaccine Product Overview
Table 63. Pfizer Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Pfizer Business Overview
Table 65. Pfizer Recent Developments
Table 66. Serum Institute of India Live Attenuated Measles Vaccine Basic Information
Table 67. Serum Institute of India Live Attenuated Measles Vaccine Product Overview
Table 68. Serum Institute of India Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Serum Institute of India Business Overview
Table 70. Serum Institute of India Recent Developments
Table 71. Novartis Live Attenuated Measles Vaccine Basic Information
Table 72. Novartis Live Attenuated Measles Vaccine Product Overview
Table 73. Novartis Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Novartis Business Overview
Table 75. Novartis Recent Developments
Table 76. Emergent Biosolutions Live Attenuated Measles Vaccine Basic Information
Table 77. Emergent Biosolutions Live Attenuated Measles Vaccine Product Overview
Table 78. Emergent Biosolutions Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Emergent Biosolutions Business Overview
Table 80. Emergent Biosolutions Recent Developments
Table 81. Bavarian Nordic Live Attenuated Measles Vaccine Basic Information
Table 82. Bavarian Nordic Live Attenuated Measles Vaccine Product Overview
Table 83. Bavarian Nordic Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Bavarian Nordic Business Overview
Table 85. Bavarian Nordic Recent Developments
Table 86. Medimmune Live Attenuated Measles Vaccine Basic Information
Table 87. Medimmune Live Attenuated Measles Vaccine Product Overview
Table 88. Medimmune Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Medimmune Business Overview
Table 90. Medimmune Recent Developments
Table 91. Johnson and Johnson Live Attenuated Measles Vaccine Basic Information
Table 92. Johnson and Johnson Live Attenuated Measles Vaccine Product Overview
Table 93. Johnson and Johnson Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Johnson and Johnson Business Overview
Table 95. Johnson and Johnson Recent Developments
Table 96. CSL Limited Live Attenuated Measles Vaccine Basic Information
Table 97. CSL Limited Live Attenuated Measles Vaccine Product Overview
Table 98. CSL Limited Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. CSL Limited Business Overview
Table 100. CSL Limited Recent Developments
Table 101. Changchun Qijian Biological Products Co., Ltd Live Attenuated Measles Vaccine Basic Information
Table 102. Changchun Qijian Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Overview
Table 103. Changchun Qijian Biological Products Co., Ltd Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Changchun Qijian Biological Products Co., Ltd Business Overview
Table 105. Changchun Qijian Biological Products Co., Ltd Recent Developments
Table 106. Beijing Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Basic Information
Table 107. Beijing Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Overview
Table 108. Beijing Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Beijing Institute of Biological Products Co., Ltd Business Overview
Table 110. Beijing Institute of Biological Products Co., Ltd Recent Developments
Table 111. Wuhan Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Basic Information
Table 112. Wuhan Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Overview
Table 113. Wuhan Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Wuhan Institute of Biological Products Co., Ltd Business Overview
Table 115. Wuhan Institute of Biological Products Co., Ltd Recent Developments
Table 116. Shanghai Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Basic Information
Table 117. Shanghai Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Overview
Table 118. Shanghai Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Shanghai Institute of Biological Products Co., Ltd Business Overview
Table 120. Shanghai Institute of Biological Products Co., Ltd Recent Developments
Table 121. Lanzhou Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Basic Information
Table 122. Lanzhou Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product Overview
Table 123. Lanzhou Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Lanzhou Institute of Biological Products Co., Ltd Business Overview
Table 125. Lanzhou Institute of Biological Products Co., Ltd Recent Developments
Table 126. Global Live Attenuated Measles Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global Live Attenuated Measles Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Live Attenuated Measles Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America Live Attenuated Measles Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Live Attenuated Measles Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe Live Attenuated Measles Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Live Attenuated Measles Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific Live Attenuated Measles Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Live Attenuated Measles Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America Live Attenuated Measles Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Live Attenuated Measles Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Live Attenuated Measles Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Live Attenuated Measles Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global Live Attenuated Measles Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Live Attenuated Measles Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global Live Attenuated Measles Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global Live Attenuated Measles Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Live Attenuated Measles Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Live Attenuated Measles Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Live Attenuated Measles Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Live Attenuated Measles Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Live Attenuated Measles Vaccine Market Size by Country (M USD)
Figure 11. Live Attenuated Measles Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Live Attenuated Measles Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Live Attenuated Measles Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Live Attenuated Measles Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Live Attenuated Measles Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Live Attenuated Measles Vaccine Market Share by Type
Figure 18. Sales Market Share of Live Attenuated Measles Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Live Attenuated Measles Vaccine by Type in 2023
Figure 20. Market Size Share of Live Attenuated Measles Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Live Attenuated Measles Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Live Attenuated Measles Vaccine Market Share by Application
Figure 24. Global Live Attenuated Measles Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Live Attenuated Measles Vaccine Sales Market Share by Application in 2023
Figure 26. Global Live Attenuated Measles Vaccine Market Share by Application (2019-2024)
Figure 27. Global Live Attenuated Measles Vaccine Market Share by Application in 2023
Figure 28. Global Live Attenuated Measles Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Live Attenuated Measles Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Live Attenuated Measles Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Live Attenuated Measles Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Live Attenuated Measles Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Live Attenuated Measles Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Live Attenuated Measles Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Live Attenuated Measles Vaccine Sales Market Share by Region in 2023
Figure 44. China Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Live Attenuated Measles Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Live Attenuated Measles Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Live Attenuated Measles Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Live Attenuated Measles Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Live Attenuated Measles Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Live Attenuated Measles Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Live Attenuated Measles Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Live Attenuated Measles Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Live Attenuated Measles Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Live Attenuated Measles Vaccine Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Live Attenuated Measles Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Live Attenuated Measles Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Live Attenuated Measles Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Live Attenuated Measles Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Live Attenuated Measles Vaccine Market Size by Country (M USD)
Figure 11. Live Attenuated Measles Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Live Attenuated Measles Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Live Attenuated Measles Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Live Attenuated Measles Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Live Attenuated Measles Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Live Attenuated Measles Vaccine Market Share by Type
Figure 18. Sales Market Share of Live Attenuated Measles Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Live Attenuated Measles Vaccine by Type in 2023
Figure 20. Market Size Share of Live Attenuated Measles Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Live Attenuated Measles Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Live Attenuated Measles Vaccine Market Share by Application
Figure 24. Global Live Attenuated Measles Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Live Attenuated Measles Vaccine Sales Market Share by Application in 2023
Figure 26. Global Live Attenuated Measles Vaccine Market Share by Application (2019-2024)
Figure 27. Global Live Attenuated Measles Vaccine Market Share by Application in 2023
Figure 28. Global Live Attenuated Measles Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Live Attenuated Measles Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Live Attenuated Measles Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Live Attenuated Measles Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Live Attenuated Measles Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Live Attenuated Measles Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Live Attenuated Measles Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Live Attenuated Measles Vaccine Sales Market Share by Region in 2023
Figure 44. China Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Live Attenuated Measles Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Live Attenuated Measles Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Live Attenuated Measles Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Live Attenuated Measles Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Live Attenuated Measles Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Live Attenuated Measles Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Live Attenuated Measles Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Live Attenuated Measles Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Live Attenuated Measles Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Live Attenuated Measles Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Live Attenuated Measles Vaccine Market Share Forecast by Application (2025-2030)
